Enveric Biosciences, Inc.

Beyond the Psychedelic Experience: Enveric Biosciences Takes Another Step Toward a New Generation of Mental Health Treatments
microdose.buzz · 22 Oct 2026
Enveric Biosciences Announces Positive Results from Recently Completed IND-enabling ADMET Studies
BioSpace · 22 Oct 2026
Enveric Biosciences announces results from IND-enabling ADMET studies
TipRanks · 21 Oct 2026
Enveric completes drug absorption studies for EB-003 candidate
Investing.com · 21 Oct 2026
Enveric Biosciences Announces Positive Results From IND-Enabling ADMET Studies
TradingView · 21 Oct 2026
Enveric Biosciences Reports Favorable Preclinical Results for Non-Hallucinogenic Psychiatric Candidate
Benzinga · 21 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.